REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Reactivos para Laboratorios Limitada (Realab) (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Reactivos para Laboratorios Limitada (Realab) Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Comercializacion de reactivos para laboratorios clinicos.comercializacion de materiales para laboratorios clinicos.comercializacion de equipos para laboratorios clinicos.

Headquarters
Cr 58 Cl 75 142 Lc 1-2
Barranquilla; Atlantico;

Contact Details: Purchase the Reactivos para Laboratorios Limitada (Realab) report to view the information.

Basic Information
Total Employees:
Purchase the Reactivos para Laboratorios Limitada (Realab) report to view the information.
Outstanding Shares:
Purchase the Reactivos para Laboratorios Limitada (Realab) report to view the information.
Registered Capital:
Purchase the Reactivos para Laboratorios Limitada (Realab) report to view the information.
Incorporation Date:
June 16, 1978
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Reactivos para Laboratorios Limitada (Realab) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-14.89%▼
Total operating revenue
-14.89%▼
Total assets
-9.14%▼
Total equity
0.65%▲
Operating Profit Margin (ROS)
-0.48%▼
Net Profit Margin
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo